Sign In
Buy ACI
$15.71
+0.120 (+0.770%)
At Close: Jun 03, 2026
Insights Into Albertsons Companies (ACI) Q3: Wall Street Projections for Key Metrics
10:16am, Thursday, 01'st Jan 2026
Besides Wall Street's top-and-bottom-line estimates for Albertsons Companies (ACI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared du
Albertsons Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
02:44am, Thursday, 01'st Jan 2026
Albertsons Companies, Inc. (NYSE: ACI) will release earnings results for the third quarter before the opening bell on Wednesday, Jan. 7, 2026.
Albertsons Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
02:44am, Thursday, 01'st Jan 2026
Albertsons Companies, Inc. (NYSE: ACI) will release earnings results for the third quarter before the opening bell on Wednesday, Jan. 7, 2026.
Mr. Market Continues To Underestimate Albertsons Companies
09:30am, Wednesday, 31'st Dec 2025
Albertsons Companies remains a ‘strong buy' due to deep undervaluation despite recent share price underperformance and margin pressure. Revenue is rising, driven by pharmacy and digital sales growth
How To Earn $500 A Month From Albertsons Companies Stock Ahead Of Q3 Earnings
08:16am, Tuesday, 30'th Dec 2025
Albertsons Companies, Inc. (NYSE: ACI) will release earnings results for the third quarter before the opening bell on Wednesday, Jan. 7, 2026.
E. Ohman J or Asset Management AB Purchases 416,493 Shares of Albertsons Companies, Inc. $ACI
04:49am, Sunday, 28'th Dec 2025
E. Ohman J or Asset Management AB grew its holdings in Albertsons Companies, Inc. (NYSE: ACI) by 32.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. T
Market Today: Records, BP--Castrol deal, Wegovy pill OK
05:35pm, Wednesday, 24'th Dec 2025
Stock News Dow and S&P 500 close at records: The S&P 500 and Dow Jones notched fresh closing highs in a holiday-shortened session, with leadership from megacaps
Albertsons® Companies Announces Third Quarter Fiscal 2025 Earnings Release and Conference Call Date
04:01pm, Tuesday, 23'rd Dec 2025
BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. will release financial results for the third quarter of fiscal 2025, before the market opens on Wednesday, Jan. 7, 2026.
Reviewing Albertsons Companies (NYSE:ACI) and Grove Collaborative (NYSE:GROV)
01:14am, Tuesday, 23'rd Dec 2025
Albertsons Companies (NYSE: ACI - Get Free Report) and Grove Collaborative (NYSE: GROV - Get Free Report) are both consumer staples companies, but which is the superior investment? We will compare the
3 Cheap Dividend Stocks That Can Beat Inflation and Pay You to Wait
10:26am, Thursday, 18'th Dec 2025
While it may not be anything like the 7% to 8% inflation rate of 2022 and 2023, the consensus view is that inflation will remain above the Federal Reserve's preferred 2% target for some time to come.
First Look: WBD rejects PSKY bid; Ford pivots; Tesla faces DMV order
07:37am, Wednesday, 17'th Dec 2025
Stock News WBD backs Netflix, rejects PSKY bid: Warner Bros. Discovery (WBD) urged shareholders to reject Paramount Skydance's (PSKY) $30-per-share hostile tend
Market Today: Jobs Cool, EU Eases Engine Ban, Oil Hits 2021 Lows
05:36pm, Tuesday, 16'th Dec 2025
Stock News U.S. labor market cools: The U.S. added 64,000 jobs in November after a 105,000 decline in October as unemployment rose to 4.6%, the highest since 20
ACI or TBBB: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 16'th Dec 2025
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Albertsons Companies, Inc. (ACI) and BBB Foods (TBBB). But which of these two stocks offers value investor
Are Investors Undervaluing Albertsons Companies (ACI) Right Now?
10:41am, Tuesday, 16'th Dec 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
02:50pm, Monday, 15'th Dec 2025
AC Immune receives a "Buy" rating, driven by positive phase 2 VacSYn trial results for ACI-7104.056 in early Parkinson's Disease. AC Immune is advancing ACI-7104.056, with upcoming FDA discussions to
